Clobenzorex

Clobenzorex
Clinical data
Other names	N-(2-chlorobenzyl)amphetamine
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	A08AA08 (WHO) ;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); CA: Schedule I; UK: Class B; US: Unscheduled;
Identifiers
	IUPAC name N-(2-chlorobenzyl)-1-phenylpropan-2-amine;
CAS Number	13364-32-4 ;
PubChem CID	71675;
ChemSpider	64732 ;
UNII	4A5352XI2A;
KEGG	D07115 ;
ChEMBL	ChEMBL1213251 ;
CompTox Dashboard (EPA)	DTXSID7048409 ;
ECHA InfoCard	100.033.108
Chemical and physical data
Formula	C16H18ClN
Molar mass	259.78 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Clc1ccccc1CNC(C)Cc2ccccc2;
	InChI InChI=1S/C16H18ClN/c1-13(11-14-7-3-2-4-8-14)18-12-15-9-5-6-10-16(15)17/h2-10,13,18H,11-12H2,1H3 ; Key:LRXXRIXDSAEIOR-UHFFFAOYSA-N ;
	(verify)

Clobenzorex is a central nervous system stimulant and anorectic drug, chemically classified as an N-substituted amphetamine and a phenethylamine. Marketed by Aventis under the trade name Asenlix in India, Mexico, Honduras, and other parts of Latin America.

A prodrug of amphetamine, clobenzorex is metabolized within hours of ingestion into 4-hydroxyclobenzorex and, in smaller amounts, amphetamine.